These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19574925)

  • 1. The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life.
    Bakheit AM
    Int J Rehabil Res; 2010 Jun; 33(2):104-8. PubMed ID: 19574925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin--mechanisms of action and clinical use in spasticity.
    Barnes M
    J Rehabil Med; 2003 May; (41 Suppl):56-9. PubMed ID: 12817658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety considerations in the use of botulinum toxins in children with cerebral palsy.
    Apkon SD; Cassidy D
    PM R; 2010 Apr; 2(4):282-4. PubMed ID: 20430330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin: from spasticity reliever to a neuromotor re-learning tool.
    Krishnan RV
    Int J Neurosci; 2005 Oct; 115(10):1451-67. PubMed ID: 16162450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for painful spasms from focal seizures: theoretical considerations and case report.
    Wilkenfeld AJ; Frank SA; McCarthy DC
    Neurologist; 2013 Jan; 19(1):15-6. PubMed ID: 23269101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When it comes to botulinum toxin, children and adults are not the same: multimuscle option for children with cerebral palsy.
    Heinen F; Schroeder AS; Fietzek U; Berweck S
    Mov Disord; 2006 Nov; 21(11):2029-30. PubMed ID: 16972275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.
    Pidcock FS
    J Pediatr; 2004 Aug; 145(2 Suppl):S33-5. PubMed ID: 15292885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
    Tilton AH
    J Child Neurol; 2003 Sep; 18 Suppl 1():S50-66. PubMed ID: 13677571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in the management of spasticity in adults.
    Turner-Stokes L; Ward A
    Clin Med (Lond); 2002; 2(2):128-30. PubMed ID: 11991094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
    Lange F; van Weerden TW; van der Hoeven JH
    Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.